Cold Plasma Market Report 2026

The cold plasma market size has grown rapidly in recent years. It will grow from $3.62 billion in 2025 to $4.26 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to growth of plasma-based medical research, expansion of electronics surface treatment needs, increasing adoption in polymer processing, rising use in food safety applications, availability of compact plasma systems.

The cold plasma market size is expected to see rapid growth in the next few years. It will grow to $8.11 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to increasing demand for non-thermal sterilization technologies, rising investments in plasma-based healthcare solutions, expansion of advanced materials processing, growing focus on sustainable treatment technologies, increasing integration in industrial manufacturing. Major trends in the forecast period include expanding use of cold plasma in medical therapies, rising adoption for surface modification applications, growing utilization in food decontamination processes, increased integration in electronics and semiconductor treatment, advancements in atmospheric plasma generation.

The rising prevalence of infectious diseases is expected to propel the growth of the cold plasma market going forward. Infectious diseases refer to illnesses caused by the invasion and multiplication of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, which can be transmitted from one individual to another through various means such as direct contact, droplets, or contaminated objects. Cold plasma technology's ability to kill bacteria and viruses is particularly valuable in healthcare settings, reducing healthcare-associated infections and providing air purification. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the rising prevalence of infectious diseases will drive the growth of the cold plasma market.

Major companies in the cold plasma market are focused on developing advanced technological solutions such as cold plasma systems to enhance surface treatment, sterilization, and medical applications. Cold plasma systems generate reactive species that can modify surfaces, kill pathogens, and promote wound healing in medical applications. For instance, in April 2024, Mirari Doctor PTE LTD, a Singapore-based company that focuses on developing advanced digital health technologies and patient management systems, launched Revolutionary Cold Plasma Technology for Skin Rejuvenation and Wound Healing. The MIRARI® Cold Plasma System equips healthcare professionals with a portable and user-friendly tool for targeted treatments, showing significant potential in dermatology, wound care, and cancer therapies. It has received approvals from the Thai FDA and Vietnam MOH, emphasizing safety, efficacy, and cost-effectiveness for enhanced patient care. Mirari Doctor aims to expand its reach globally to benefit more patients.

In April 2023, Judges Scientific plc, a UK-based scientific instrumentation company, acquired Henniker Scientific Limited for an undisclosed amount. Through this acquisition, Judges Scientific aims to enhance its capabilities in plasma surface treatment, thin-film deposition, and nano-scale instrumentation. Henniker Scientific Limited is a UK-based company that provides cold plasma solutions through its range of equipment and services for surface treatment and processing.

Major companies operating in the cold plasma market are Nordson Corporation, Plasma Etch Inc., Adtech Plasma Technology Co. Ltd., P2i Limited, Relyon Plasma GmbH, Henniker Plasma Treatment, Enercon Industries Corporation, AcXys Plasma Technologies, Plasmatreat GmbH, Europlasma NV, SOFTAL Corona & Plasma GmbH, UNIQAIR Technologies Ltd., CINOGY System GmbH, neoplas med GmbH, Leaflife Technology Co. Ltd., Nova Plasma Ltd., Tantec A/S, Surfx Technologies LLC, Coating Plasma Innovation, Ferrarini & Benelli Srl, terraplasma GmbH, Molecular Plasma Group, Advanced Plasma Solutions Co. Inc., PlasmaLeap Technologies, COMET Plasma Control Technologies.

Asia-Pacific was the largest region in the cold plasma market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cold plasma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cold plasma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold plasma market consists of sales of cold plasma derived from techniques such as corona discharge and plasma jet. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.